Clinical Review: Thyrotoxic periodic paralysis: A diagnostic challenge

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 7, 2006, Pages 2490-2495

  Kung, Annie W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; CARBOHYDRATE; ELECTROLYTE; METOPROLOL; POTASSIUM; POTASSIUM CHLORIDE; PROPRANOLOL; RADIOACTIVE IODINE; THYROID HORMONE; THYROXINE;

ASIAN; CARDIOPULMONARY FUNCTION; CLINICAL FEATURE; DNA POLYMORPHISM; ELECTRODIAGNOSIS; GENETIC PREDISPOSITION; HUMAN; HYPERKALEMIA; HYPERTHYROIDISM; HYPOKALEMIA; HYPOKALEMIC PERIODIC PARALYSIS; INCIDENCE; INSULIN RESPONSE; MUSCLE WEAKNESS; PARALYSIS; PATHOGENESIS; PERIODIC PARALYSIS; POTASSIUM CELL LEVEL; POTASSIUM DEFICIENCY; PRIORITY JOURNAL; REBOUND; RECURRENT DISEASE; REMISSION; REVIEW; THYROIDECTOMY; THYROTOXIC PERIODIC PARALYSIS;

ANTITHYROID AGENTS; ASIA; ELECTROMYOGRAPHY; EXERCISE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; HYPOKALEMIA; HYPOKALEMIC PERIODIC PARALYSIS; IODINE RADIOISOTOPES; MALE; MEDLINE; MUSCLE, SKELETAL; MUSCULAR DISEASES; NA(+)-K(+)-EXCHANGING ATPASE; PARALYSIS; PERIODICITY; POTASSIUM; POTASSIUM CHLORIDE; THYROID HORMONES; THYROIDECTOMY; THYROTOXICOSIS;

EID: 33745786609     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0356     Document Type: Review

References (69)

1. McFadzean AJS, Yeung R 1967 Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J 1:451-455
2. Okinaka S, Shizume K, Lino S, Watanabe A, Irie M, Noguchi A, Kuma S, Kuma K, Ito T 1957 The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab 17:1454-1459
3. Ober KP 1992 Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine 71:109-120
4. Kelley DE, Gharib H, Kennedy FP, Duda RJ, McManis MB 1989 Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med 149:2597-2600
5. Layzer RB 1990 Neuromuscular manifestation of endocrine disease. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. Philadelphia: JB Lippincott; 1536
6. Wendorf M, Goldfine ID 1991 Archaeology of NIDDM. Excavation of the "thrifty" genotype. Diabetes 40:161-165
7. Tinker TD, Vannatta JB 1987 Thyrotoxic hypokalemic periodic paralysis: report of four cases and review of the literature. J Okla State Med Assoc 80:76-83 (Review)
8. Ko GTC, Chow CC, Yeung VTF, Chan HHL, Li JKY, Cockram CS 1996 Thyrotoxic periodic paralysis in a Chinese population. Q J Med 89:463-468
9. Shizume K, Shishiba Y, Kuma K, Noguchi S, Tajiri J, Ito K, Noh JY 1992 Comparison of the incidence of association of periodic paralysis and hyperthyroidism in Japan in 1957 and 1991. Endocrinol Jpn 39:315-318
10. Wong GW, Leung TF, Lo AF, Ahuja AT, Cheng PS 2000 Thyrotoxic periodic paralysis in a 14-year-old boy. Eur J Pediatr 159:934
11. Schalin-Jantti C, Laine T, Valli-Jaakola K, Lonnqvist T, Kontula K, Valimaki MJ 2005 Manifestation, management and molecular analysis of candidate genes in two rare cases of thyrotoxic hypokalemic periodic paralysis. Horm Res 63:139-144
12. Liu YC, Tsai WS, Chau T, Lin SH 2004 Acute hypercapnic respiratory failure due to thyrotoxic periodic paralysis. Am J Med Sci 327:264-267
13. Ahlawat SK, Sachdev A 1999 Hypokalemic paralysis. Postgrad Med J 75:193-197
14. Crane MG 1960 Periodic paralysis associated with hyperthyroidism. Calif Med 92:285-288
15. Schutta HS, Armitage JL 1969 Thyrotoxic hypokalemic periodic paralysis. J Neuropath Exp Neurol 28:321-336
16. Talbott JH 1941 Periodic paralysis. Medicine 20:85-142
17. Lapie P, Lory P, Fontaine B 1997 Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. Neuromuscul Disord 7:234-240 (Review)
18. Links TP, Smit AJ, Molenaar WM, Zwarts MJ, Oosterhuis HJ 1994 Familial hypokalemic periodic paralysis. Clinical, diagnostic and therapeutic aspects. J Neurol Sci 122:33-43
19. Papadopoulos KI, Diep T, Cleland B, Lunn NW 1997 Thyrotoxic periodic paralysis: report of three cases and review of the literature. J Intern Med 241:521-524
20. Kung AWC 2002 Thyrotoxic periodic paralysis. In: Wass JAH, Shalet SM, eds. Oxford textbook of endocrinology and diabetes. Oxford, UK: Oxford University Press; 427-429
21. Norris Jr FH, Clark EC, Biglieri EG 1972 Studies in thyrotoxic periodic paralysis. Metabolic and ultrastructural studies. Arch Neurol Sci 13:431-432
22. Hsu FS, Tsai WS, Chau T, Chen HH, Chen YC, Lin SH 2003 Thyrotopin-secreting pituitary adenoma presenting as hypokalemic periodic paralysis. Am J Med Sci 325:48-50
23. Okihiro MM, Nordyke RA 1966 Hypokalemic periodic paralysis: experimental precipitation with sodium liothyronine. JAMA 198:949-951
24. Tran HA 2005 Inadvertent iodine excess causing thyrotoxic hypokalemic periodic paralysis. Arch Intern Med 165:2536
25. Akar S, Comlekci A, Biklik M, Onen F, Sari I, Gurler O, Bekis R, Akkoc N 2005 Thyrotoxic periodic paralysis in a Turkish male: the recurrence of the attack after radioiodine treatment. Endocr J 52:149-151
26. Nora NA, Berns AS 1989 Hypokalemic, hypophosphatemic thyrotoxic periodic paralysis. AM J Kidney Dis 13:247-249
27. Lin SH 2005 Thyrotoxic periodic paralysis. Mayo Clin Proc 80:99-105 (Review)
28. Fisher J 1982 Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med 142:1362-1364
29. Loh KC, Pinheiro L, Ng KS 2005 Thyrotoxic period paralysis complicated by near-fatal ventricular arrhythmias. Singapore Med J 46:88-89
30. Randall BB 1992 Fatal hypokalemic thyrotoxic periodic paralysis presenting as the sudden, unexplained death of a Cambodian refugee. Am J Forensic Med Pathol 13:204-206
31. Manoukian MA, Foote JA, Crapo LM 1999 Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 159:601-606
32. Norris KC, Levine B, Ganesan K 1996 Case report: thyrotoxic periodic paralysis associated with hypokalemia and hypophosphatemia. Am J Kidney Dis 28:272-273
33. Ryzen E, Servis KL, Rude RK 1990 Effect of intravenous epinephrine on serum magnesium and free intracellular red blood cell magnesium concentrations measured by nuclear magnetic resonance. J Am Coll Nutr 9:114-119
34. Tengan CH, Antunes AC, Gabbai AA, Manzano GM 2004 The exercise test as a monitor of disease status in hypokalaemic periodic paralysis. J Neurol Neurosurg Psychiatry 75:497-499
35. Hsu YJ, Lin YF, Chau T, Liou JT, Kuo SW, Lin SH 2003 Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis. Am J Med Sci 326:128-132
36. +-ATPase activity of erythrocytes and leucocytes in thyroid disease. Clin Sci 72:171-179
37. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R 1991 In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. Br Med J 303:1096-1099
38. Lam KSL, Yeung RTT, Benson EA, Wang C 1989 Erythrocyte sodium-potassium pump in thyrotoxic periodic paralysis. Aust NZ J Med 19:6-10
39. + adenosine triphosphatase. J Biol Chem 251:7834-7840
40. Curfman GD, Crowley TJ, Smith TW 1977 Thyroid-induced alterations in myocardial sodium-potassium-activated adenosine triphosphatase, monovalent cation active transport, and cardiac glycoside binding. J Clin Invest 59:586-590
41. +-ATPase concentrations in various tissues of rats caused by thyroid hormone treatment. J Biol Chem 253:723-726
42. +-adenosine triphosphatase activity in the action of thyroid hormone on rat jejunal mucosa. Biophys J 27:127-144
43. Blanco G, Mercer RW 1998 Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol 275:F633-F650
44. Pestov NB, Adams G, Shakhparonov MI, Modyanov NN 1999 Identification of a novel gene of the X, K-ATPase β-subunit family that is predominantly expressed in skeletal and heart muscles. FEBS Lett 275:243-248
45. Chaudhury S, Ismail-Beigi F, Gick GG, Lavenson R, Edelman IS 1987 Effect of thyroid hormone on the abundance of Na, K-adenosine triphosphatase α-subunit messenger ribonucleic acid. Mol Endocrinol 1:83-89
46. Desai-Yajinik V, Zeng J, Omorik, Sherman J, Morimoto T 1995 The effect of thyroid hormone treatment on the gene expression and enzyme activity of rat liver sodium potassium dependent adenosine triphosphatase. Endocrinology 136:629-639
47. Layzer RB 1982 Periodic paralysis and the sodium-potassium pump. Ann Neurol 11:547-552
48. Shishiba Y, Shimuzu T, Saito T, Shizuma K 1972 Elevated immunoreactive insulin concentration during spontaneous attacks in thyrotoxic periodic paralysis. Metabolism 21:285-290
49. Lee KO, Taylor EA, Oh VMS, Cheah JS, Aw SE 1991 Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis. Lancet 337:1063-1064
50. Hundal HS, Marette A, Mitsumoto Y, Ramlal T, Blostein R, Klip A 1992 Insulin induces translocation of the α2 and β1 subunits of the Na+/K(+)-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle. J Biol Chem 267:5040-5043
51. Hawkins BR, Ma JTC, Lam KSL, Wang CCL, Yeung RTT 1985 Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese. Clin Endocrinol (Oxf) 23:245-252
52. Yeo PPB, Chan SH, Lui KF, Wu GB, Lim P, Cheah JS 1978 HLA and thyrotoxic periodic paralysis. Br Med J 2:930
53. Tamai H, Tanaaha K, Komaki G, Matsubayashi S, Hirota Y, Mori K, Kuma K, Kumagai L, Nagataki S 1987 HLA and thyrotoxic periodic paralysis in Japanese patients. J Clin Endocrinol Metab 64:1075-1078
54. v1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis. Clin Endocrinol (Oxf) 56:367-375
55. v1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab 89:1340-1345
56. Dias de Silva MR, Cerutti JM, Arnaldi LA, Maciel RM 2002 A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J Clin Endocrinol Metab 87:4881-4884
57. Lane AH, Markarian K, Braziunene I 2004 Thyrotoxic periodic paralysis associated with a mutation in the sodium channel gene SCN4A. J Pediatr Endocrinol Metab 17:1679-1682
58. Ng WY, Lui KF, Thai AC, Cheah JS 2004 Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. Thyroid 14:187-190
59. Wang W, Jiang L, Ye L, Zhu N, Su T, Guan L, Li X, Ning G 2006 Mutation screening in Chinese hypokalemic periodic paralysis patients. Mol Genet Metab 87:359-363
60. Kung AWC, Lau KS, Cheung WMW, Chan V 2006 Thyrotoxic periodic paralysis and polymorphisms of sodium-potassium ATPase genes. Clin Endocrinol (Oxf) 64:158-161
61. Kim TY, Song JY, Kim WB, Shong YK 2005 Arg16Gly polymorphism in β2-adrenergic receptor gene is not associated with thyrotoxic periodic paralysis in Korean male patients with Graves' disease. Clin Endocrinol (Oxf) 62:585-589
62. Lu KC, Hsu YJ, Chiu JS, Hsu YD, Lin SH 2004 Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. Am J Emerg Med 22:54454-54457
63. Shayne P, Hart A 1994 Thyrotoxic periodic paralysis terminated with intravenous propranolol. Ann Emerg Med 24:736-740
64. Birkhahn RH, Gaeta TJ, Melniker L 2000 Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting. J Emerg Med 18:199-202
65. Tassone H, Moulin A, Henderson SO 2004 The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature. J Emerg Med 26:157-161
66. Lin SH, Lin YF 2001 Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis 37:620-623
67. Young RTT, Tse TF 1974 Thyrotoxic periodic paralysis. Effect of propranolol. Am J Med 57:584-590
68. Shulkin D, Olson BR, Levey GS 1989 Thyrotoxic periodic paralysis in a Latin-American taking acetazolamide. Am J Med Sci 297:337-338
69. Chen YC, Fang JT, Chang CT, Chou HH 2001 Thyrotoxic periodic paralysis in a patient abusing thyroxine for weight reduction. Ren Fail 23:139-142